Zacks Investment Research on MSN
PacBio & Lucid Genomics partner to boost data analysis, stock up
PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...
PacBio’s Compatible partner program recognizes third-party providers whose solutions have been evaluated to work seamlessly with PacBio instruments and data formats. As a named partner, Lucid Genomics ...
The workflow leverages Covaris’ Adaptive Focused Acoustics ® (AFA)-based truXTRAC FFPE extraction method to recover longer DNA fragments, up to 5,000 base pairs, from FFPE tissues. PacBio’s Kinnex ...
MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
10hon MSN
Cheaper sequencing, bigger payoff: New software could bring advanced metagenomics to more labs
Metagenomics relies on the use of software programs called assemblers, which can reconstruct tens of thousands of individual ...
Zacks Investment Research on MSN
PacBio stock up on new FFPE workflow boosting cancer sequencing
PacBio PACB recently announced a new joint workflow with Covaris, a PerkinElmer company and leader in sample preparation ...
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University ...
BOSTON, Oct. 30, 2024 /PRNewswire/ -- Volta Labs™, a genomics applications company, announced today that it has joined the PacBio Compatible program, further expanding the partnership between Volta ...
PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics MENLO PARK, Calif., March 18, 2026 (GLOBE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results